Review
doi: 10.1016/0306-039x(76)90016-7.
6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome
- PMID: 772721
- DOI: 10.1016/0306-039x(76)90016-7
Item in Clipboard
Review
6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome
Pharmacol Ther B.
1976.
No abstract available
Similar articles
-
Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.
-
Further evidence for the stimulation of rat brain dopamine receptors by ergometrine.J Pharm Pharmacol. 1974 Jun;26(6):455-6. doi: 10.1111/j.2042-7158.1974.tb09313.x. J Pharm Pharmacol. 1974. PMID: 4154992 No abstract available.
-
Effects of chronic morphine treatment on dopamine-mediated turning behaviour in rats and mice with 6-hydroxydopamine-induced unilateral nigro-striatal lesions.Neuropharmacology. 1980 Mar;19(3):289-95. doi: 10.1016/0028-3908(80)90152-5. Neuropharmacology. 1980. PMID: 7191487 No abstract available.
-
Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.Eur J Pharmacol. 1979 Dec 7;60(2-3):163-70. doi: 10.1016/0014-2999(79)90215-2. Eur J Pharmacol. 1979. PMID: 575095 No abstract available.
-
Inhibitory mechanisms in the substantia nigra and the dopamine pathway.Int J Neurol. 1979;13(1-4):81-93. Int J Neurol. 1979. PMID: 122391 Review. No abstract available.
Cited by
-
The Proteasome Inhibition Model of Parkinson's Disease.J Parkinsons Dis. 2017;7(1):31-63. doi: 10.3233/JPD-160921. J Parkinsons Dis. 2017. PMID: 27802243 Free PMC article. Review.
-
Prism adaptation for spatial neglect after stroke: translational practice gaps.Nat Rev Neurol. 2012 Oct;8(10):567-77. doi: 10.1038/nrneurol.2012.170. Epub 2012 Aug 28. Nat Rev Neurol. 2012. PMID: 22926312 Free PMC article. Review.
-
Comparison of the D₁ dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease.Psychopharmacology (Berl). 2012 Jul;222(1):81-7. doi: 10.1007/s00213-011-2625-5. Epub 2012 Jan 6. Psychopharmacology (Berl). 2012. PMID: 22222862
-
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity.Proc Natl Acad Sci U S A. 1998 May 12;95(10):5789-94. doi: 10.1073/pnas.95.10.5789. Proc Natl Acad Sci U S A. 1998. PMID: 9576963 Free PMC article.
-
Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test.J Vis Exp. 2010 Jan 15;(35):1376. doi: 10.3791/1376. J Vis Exp. 2010. PMID: 20081770 Free PMC article.